Test product of mirabegron,Reference product of mirabegron
Sponsors
Novartis (Thailand) Ltd.
Conditions
Overactive bladder syndrome
Overactive bladder syndrome
OABOveractive bladder syndrome
Overactive bladder syndrome OAB
Phase 1
A Bioequivalence Study of Two Formulations of 50-mg Mirabegron Prolonged Release Tablets in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20220223005
Start: 2022-06-15Target: 54Updated: 2026-08-03
A Bioequivalence Study of Two Formulations of 50-mg Mirabegron Prolonged Release Tablets in Healthy Thai Volunteers under Fed Conditions
Active, not recruitingTCTR20220223006
Start: 2022-06-27Target: 44Updated: 2026-08-03